SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Priv. Ord Regulatory News (CTPE)

Share Price Information for Ct Priv. Ord (CTPE)

Share Price is delayed by 15 minutes
Get Live Data
500.00    7.50 (1.53%)
Bid:
495.00
Ask:
500.00
Spread: 5.00 (1.01%)
Market Cap: £357.51m
CTPE Live PriceLast checked at - London Stock Exchange

Intraday Ct Priv. Ord Share Chart

Kepler Trust Intelligence: New Research

29 Dec 2022 07:00

RNS Number : 0996L
CT Private Equity Trust PLC
29 December 2022
Β 

CT Private Equity: New ResearchΒ 

29/12/2022

CTPE's differentiated strategy continues to deliver strong results…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

Β 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

Β 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word β€œReach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAPPGPAPUPPGGR
Date   Source Headline
11th Jun 20261:16 pmRNSDirector/PDMR Shareholding
2nd Jun 20264:38 pmRNSDirector/PDMR Shareholding
1st Jun 202611:01 amRNSTotal Voting Rights
28th May 20264:59 pmRNSAnnual General Meeting and Directorate Change
28th May 202611:21 amRNSQuarterly Results and Dividend Announcement
1st May 202611:39 amRNSTotal Voting Rights
21st Apr 20267:00 amRNSChange in Directorate
21st Apr 20267:00 amRNSAnnual Financial Report
1st Apr 202610:26 amRNSTotal Voting Rights
27th Mar 20267:00 amRNSPreliminary Results and Dividend Announcement
19th Mar 20267:00 amRNS-RInvestor Presentation
2nd Mar 20263:04 pmRNSTotal Voting Rights
3rd Feb 202610:37 amRNSTotal Voting Rights
8th Jan 202611:48 amRNSDirector/PDMR Shareholding
2nd Jan 202610:28 amRNSTotal Voting Rights
22nd Dec 20257:00 amRNSDirectorate Change
22nd Dec 20257:00 amRNSDirectorate Change
10th Dec 20257:00 amRNS-RKepler Trust Intelligence: New Research
1st Dec 202511:10 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSLead Fund Manager Succession
27th Nov 20257:00 amRNSThird Quarter Results and Dividend Declaration
24th Nov 20259:37 amRNS-RInvestor Presentation
6th Nov 20251:44 pmRNS-RProfessional Investor Presentation
3rd Nov 20259:17 amRNSTotal Voting Rights
1st Oct 202510:19 amRNSTotal Voting Rights
2nd Sep 20252:56 pmRNSTotal Voting Rights
28th Aug 202512:50 pmRNS-RQuotedData's In The HotSeat Special
28th Aug 20257:00 amRNSInterim Results and Dividend Announcement
20th Aug 20257:00 amRNS-RInvestor Presentation
1st Aug 202510:29 amRNSTotal Voting Rights
1st Jul 20259:55 amRNSTotal Voting Rights
2nd Jun 202510:08 amRNSTotal Voting Rights
29th May 20253:17 pmRNSResult of AGM
29th May 20251:00 pmRNSQuarterly Results And Dividend Announcement
1st May 202510:27 amRNSTotal Voting Rights
15th Apr 20257:00 amRNSAnnual Financial Report
9th Apr 20254:07 pmRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNS-RKepler Trust Intelligence: New Research
1st Apr 202511:06 amRNSTotal Voting Rights
28th Mar 20257:00 amRNSPreliminary results and Dividend Announcement
25th Mar 20252:44 pmRNS-RInvestor Presentation
3rd Mar 20251:19 pmRNSTotal Voting Rights
3rd Feb 20251:14 pmRNSTotal Voting Rights
2nd Jan 202511:19 amRNSTotal Voting Rights
2nd Dec 20249:30 amRNSDirector/PDMR Shareholding
2nd Dec 20249:25 amRNSTotal Voting Rights
29th Nov 202412:26 pmRNSDirector/PDMR Shareholding
28th Nov 20247:00 amRNSQuarterly Results and Dividend Announcement
1st Nov 20249:16 amRNSTotal Voting Rights
1st Oct 202411:09 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.